Related Experiment Videos

p85β phosphoinositide 3-kinase subunit regulates tumor progression

Isabel Cortés1, Jesús Sánchez-Ruíz, Susana Zuluaga

  • 1Department of Immunology and Oncology, Centro Nacional de Biotecnología/Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid, 28049 Madrid, Spain.

Proceedings of the National Academy of Sciences of the United States of America
|June 27, 2012
PubMed

Insights

Increased expression of p85β, a subunit of PI3K, is linked to breast and colon cancer progression. This elevated p85β enhances cell invasion and tumor growth, suggesting a key role in cancer development.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • PIK3R2 encodes the p85β regulatory subunit of phosphatidylinositol 3-kinase (PI3K).
  • PI3K enzymes generate 3-polyphosphoinositides, crucial for cell survival and migration.
  • Aberrant PI3K pathway activation is implicated in various cancers.

Purpose of the Study:

  • To investigate the role of p85β expression in cancer progression.
  • To determine the correlation between p85β levels and PI3K pathway activation.
  • To assess the functional impact of p85β on cell invasion and tumor growth.

Main Methods:

  • Analysis of p85β expression in breast and colon carcinoma tissues.
  • Correlation studies between p85β expression, PI3K pathway activation markers, and tumor stage.
  • In vitro assessment of cell membrane PIP(3) generation and cell invasion.
  • In vivo studies involving genetic alteration of pik3r2 expression.

Main Results:

  • Elevated p85β expression was observed in breast and colon carcinomas.
  • Increased p85β levels correlated with enhanced PI3K pathway activation and tumor progression.
  • p85β expression promoted PIP(3) generation and augmented cell invasion.
  • Modulation of pik3r2 expression affected tumor progression in vivo.

Conclusions:

  • Elevated p85β expression is a significant factor in cancer progression.
  • p85β acts as a cellular strategy to enhance invasion and survival in carcinomas.
  • Targeting p85β or the PI3K pathway may offer therapeutic strategies for cancer.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...